Showing 1 - 12 results of 12 for search 'Jiu‐Wei Cui', query time: 0.05s Refine Results
  1. 1
    Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis

    Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis by Wen-Jun Wang, Ling-Yu Li, Jiu-Wei Cui

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

    Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer by Jie Dong, Xu Wang, Yu Yu, Xu Yan, Jiu-Wei Cui

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients

    Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients by Wen‐Qian Li, Ling‐Yu Li, Jin Chai, Jiu‐Wei Cui

    Published 2021-03-01
    Get full text
    Article
  4. 4
    A brand new era of cancer immunotherapy: breakthroughs and challenges

    A brand new era of cancer immunotherapy: breakthroughs and challenges by Ri-Lan Bai, Nai-Fei Chen, Ling-Yu Li, Jiu-Wei Cui, Jing Ni

    Published 2021-06-01
    Get full text
    Article
  5. 5
    The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively

    The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively by Wen‐Qian Li, Han‐Fei Guo, Ling‐Yu Li, Yong‐Fei Zhang, Jiu‐Wei Cui

    Published 2021-07-01
    Get full text
    Article
  6. 6
    First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer: a cost-effectiveness analysis from China

    First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer: a cost-effectiveness analysis from China by Ling-Yu Li, Hong Wang, Xiao Chen, Wen-Qian Li, Jiu-Wei Cui, Li-Min Chen

    Published 2019-12-01
    Get full text
    Article
  7. 7
    Development of Formulas for Calculating L3 Skeletal Muscle Mass Index and Visceral Fat Area Based on Anthropometric Parameters

    Development of Formulas for Calculating L3 Skeletal Muscle Mass Index and Visceral Fat Area Based on Anthropometric Parameters by Wei Ji, XiangLiang Liu, Yiqun Zhang, Yixin Zhao, YuWei He, JiuWei Cui, Wei Li

    Published 2022-06-01
    Get full text
    Article
  8. 8
    The efficacy of fat-free mass index and appendicular skeletal muscle mass index in cancer malnutrition: a propensity score match analysis

    The efficacy of fat-free mass index and appendicular skeletal muscle mass index in cancer malnutrition: a propensity score match analysis by Wei Ji, XiangLiang Liu, Pengfei Liu, YuWei He, YiXin Zhao, Kaiwen Zheng, JiuWei Cui, Wei Li

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

    Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer by Wen-Qian Li, Ling-Yu Li, Ri-Lan Bai, Lei Qian, Nai-Fei Chen, Jiu-Wei Cui, Ning-Ning Wang

    Published 2020-11-01
    Get full text
    Article
  10. 10
    Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

    Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma by Xiang-Liang Liu, Ri-Lan Bai, Xiao Chen, Yu-Guang Zhao, Xu Wang, Ke-Wei Ma, Hui-Min Tian, Fu-Jun Han, Zi-Ling Liu, Lei Yang, Wei Li, Fei Gai, Jiu-Wei Cui, Pei-Fang Wei

    Published 2021-10-01
    Get full text
    Article
  11. 11
    Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trialResearch in context

    Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8):... by Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, Yingying Du, Jiu-Wei Cui, Qian Chu, Bing-Fei Xu, Ming-Ying Zheng, Jia-Yi Deng, Chang Lu, Xue-Wu Wei, Yang-Si Li, Mei-Mei Zheng, Ming-Yi Yang, Jie Huang, Anna Li, Xiao-Yan Bai, Yue-Li Sun, Chong-Rui Xu, Bin-Chao Wang, Hua-Jun Chen, Jin-Ji Yang, Hong-Hong Yan, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

    Published 2023-10-01
    Get full text
    Article
  12. 12
    Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

    Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma by Long-Hua Guo, Ming-Feng Zhang, He-Long Zhang, Jian-Ying Zhou, Xiao-Hong Cai, Yu Long, Qi-Sen Guo, Nong Yang, Jun Zhao, Zhan-Hong Xie, Bo Jiang, Ying Zhu, Yun Fan, Cong-Ying Xie, Yi Hu, Yu Yao, Jun Jia, Xiao-Ling Li, Jiu-Wei Cui, Xi-Zhao Sui, Wen Lin, Ying Cheng, Hui-Juan Wang, Chang-Li Wang, Ming-Fang Zhao, Gui-Bin Qiao, Li-Jun Peng, Lin Yang, Gong-Yan Chen, Kai-Can Cai, Xin-Hua Xu, Liang-Ming Zhang, Guo-Sheng Feng, Jing-Min Zhou, Guo-Wu Wu, Xiao-Rong Dong, Li-Feng Wang, Hong-Mei Zhang, Ya-Jie Gao, Qiu-Ying Jiang, Shun-Dong Cang, Zhi-Xiong Yang, Xia Song, Xiao-Qing Liu, Bo Zhu, Feng-Xia Chen, Chun-Hong Hu, Xi Chen, Yi-Long Wu, Qing Zhou

    Published 2020-09-01
    Get full text
    Article

Search Tools: